GLAND.NS Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 bal. 2024 @ 10:11):

Stats
Šios dienos apimtis	105 123
Vidutinė apimtis	497 818
Rinkos kapitalizacija	282.36B
EPS	INR11.65 ( 2024-02-14 )
Kita pelno data	( INR13.32 ) 2024-05-15
Last Dividend	INR0 ( N/A )
Next Dividend	INR0 ( N/A )
P/E	42.94
ATR14	INR0.999 (0.06%)

Tūris Koreliacija

Ilgas: 0.06 (neutral)

Trumpas: -0.16 (neutral)

Signal:(49.891) Neutral

Gland Pharma Limited Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
PIDILITIND.NS	0.939
AARTIIND.NS	0.936
PAGEIND.NS	0.935
BRFL.NS	0.934
ATUL.NS	0.933
DEVYANI.NS	0.932
MSUMI.NS	0.926
MCDOWELL-N.NS	0.922
RAJMET.NS	0.918
PIXTRANS.NS	0.917

10 Labiausiai neigiamai susiję koreliacijos
GENCON.NS	-0.915
DFMFOODS.NS	-0.9
JSL.NS	-0.89
MBAPL.NS	-0.885
SUNFLAG.NS	-0.875
MAGNUM.NS	-0.873
TOUCHWOOD.NS	-0.857
ACI.NS	-0.856
GTNIND.NS	-0.854
RAJRILTD.NS	-0.853

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Gland Pharma Limited Koreliacija - Valiuta/Žaliavos

0.46
( neutral )

0.79
( moderate )

0.66
( moderate )

-0.36
( neutral )

0.10
( neutral )

-0.68
( moderate negative )

Gland Pharma Limited Finansinės ataskaitos

Annual	2022
Pajamos:	INR36.25B
Bruto pelnas:	INR19.39B (53.50 %)
EPS:	INR47.44

FY	2022
Pajamos:	INR36.25B
Bruto pelnas:	INR19.39B (53.50 %)
EPS:	INR47.44

FY	2022
Pajamos:	INR43.84B
Bruto pelnas:	INR22.75B (51.89 %)
EPS:	INR73.81

FY	2021
Pajamos:	INR34.24B
Bruto pelnas:	INR19.32B (56.42 %)
EPS:	INR63.07

Financial Reports:

No articles found.

Gland Pharma Limited

Gland Pharma Limited engages in the development, manufacture, and marketing of injectable-focused generic liquid parenteral products. The company's primary molecules include heparin sodium, enoxaparin sodium, rocuronium bromide, and daptomycin injections, as well as others. It offers its products under various therapeutic categories, such as anti-infectives, anesthetics, anti-coagulants and their antidotes, anti-malarial, cardiology, gastro-intestinal, pain management, hormones and related drugs, fertility supplements, Gnrh agonists and antagonists, anti-neoplastic, gynecological, neurological and central nervous system, respiratory, blood related, ophthalmological and otological, pain/analgesics, orthopedics, hematinic, vitamins/minerals/nutrients, and others. The company also provides contract development services. It sells its products primarily under a business to business in the United States, Europe, Canada, Australia, India, and internationally. The company was incorporated in 1978 and is based in Hyderabad, India. Gland Pharma Limited is a subsidiary of Fosun Pharma Industrial Pte. Ltd.